Introducing the Future of Gut Health—Cobiotics

Introducing the Future of Gut Health—Cobiotics

Dean Stull, PhD, is president and CEOEO of NuMe Health, a developer of cobiotic supplements designed to alter gut bacteria for the management of chronic health conditions. Stull is an expert in botanically-derived pharmaceuticals, and has held leadership roles at Pyxant Laboratories, Efficas, Hauser and Paxis Pharmaceuticals. NBJ spoke with Stull from our offices in Boulder, Colorado.

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.

TAGS: Archive News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.